Skip to main content
Signal8
Launch Terminal

IceCure Medical Ltd. (ICCM)

Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Devices

IceCure Medical Ltd logo

IceCure Medical Ltd

NASDAQ:ICCMHealthcare
-9.05%$0.8701
AH$0.9390+7.92%vs close
Mkt Cap$4.04M
Float3.54M
O/S4.64M
Vol
$ Vol
RVOL
Inst Own2.8%
Earnings
Dilution
IceCure Medical Ltd logoNASDAQ:ICCM$0.8701-9.05%
FormDescription
6-K
REPORT OF FOREIGN PRIVATE ISSUER
2
6-K
CURRENT REPORT
3
6-K
REPORT OF FOREIGN PRIVATE ISSUER
2
6-K
CURRENT REPORT
2
6-K
REPORT OF FOREIGN PRIVATE ISSUER
6-K
REPORT OF FOREIGN PRIVATE ISSUER
4
EFFECT
Notice of Effectiveness
1
EFFECT
Notice of Effectiveness
1
4
Statement of Changes in Beneficial Ownership
3
Initial Statement of Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
S-8
REGISTRATION STATEMENT
3
6-K
REPORT OF FOREIGN PRIVATE ISSUER
2
13G
Beneficial Ownership Report
POS AM
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1
7
POS AM
POST-EFFECTIVE AMENDMENT NO. 4 TO FORM F-1
6
6-K
REPORT OF FOREIGN PRIVATE ISSUER
6
6-K
REPORT OF FOREIGN PRIVATE ISSUER
1
6-K
REPORT OF FOREIGN PRIVATE ISSUER
2
EFFECT
Notice of Effectiveness
6-K
CURRENT REPORT

1-25 of 315

…

Recent SEC filings with analysis

    IceCure Medical Ltd. (ICCM) SEC Filings: 10-K, 10-Q, 8-K, Form 4 | Signal8